Skip to main content
Equibles

STEPHENS INC /AR/

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 757657 LITTLE ROCK, AR
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$518,161
-$167,170 QoQ
Shares Held
831
-6.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#796
of 1,329 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEPHENS INC /AR/ holds $5,988,068 across 12 Biotechnology names. REGN ranks #4 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,900 $1,440,517
2 TECH
BIO-TECHNE Corp
 12,036 $850,343
3 TWST
Twist Bioscience Corp
 5,167 $531,580
4 REGN
Regeneron Pharmaceuticals, Inc.
This page 		831 $518,161
5 LGND
Ligand Pharmaceuticals Inc
 1,625 $513,646
6 EXEL
Exelixis, Inc.
 9,079 $493,988
7 ALNY
Alnylam Pharmaceuticals, Inc.
 1,638 $493,087
8 HALO
Halozyme Therapeutics, Inc.
 4,954 $387,749

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $518,161 831
2026-03-31 $685,331 887
2025-12-31 $409,091 530
2025-09-30 $304,188 541
2025-06-30 $392,700 748
2025-03-31 $566,367 893
2024-12-31 $675,288 948
2024-09-30 $1,002,882 954
2024-06-30 $1,003,733 955
2024-03-31 $878,753 913
2023-12-31 $633,247 721
2023-09-30 $524,225 637
2023-06-30 $461,302 642
2023-03-31 $531,620 647
2022-12-31 $518,751 719
2022-09-30 $495,297 719
2022-06-30 $430,933 729
2022-03-31 $511,243 732
2021-12-31 $462,272 732
2021-09-30 $446,017 737
2021-06-30 $415,553 744
2021-03-31 $399,330 844
2020-12-31 $6,881,901 14,245
2020-09-30 $7,426,601 13,267
2020-06-30 $8,118,675 13,018
2020-03-31 $6,427,361 13,163